Skip to main content

Table 2 Clinical outcomes

From: Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study

Variable

Esmolol-treated patients (n = 7)

OFFD among all patients (units)

26 (24.5–26)

OFFD among 28-day survivors (days)

26 (24.5–26)

ICU LOS among survivors (days)

3.3 (3.1–5.4)

Hospital LOS among survivors (days)

8.2 (7.1–17.3)

Mortality

 In-hospital mortality, n (%)

0 (0%)

 28-day all-cause mortality, n (%)

0 (0%)

 90-day all-cause mortality, n (%)

0 (0%)

  1. OFFD organ-failure-free days, ICU intensive care unit, LOS length of stay